Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study
- PMID: 12963897
- DOI: 10.1067/s0190-9622(03)01152-6
Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study
Abstract
This multicenter, randomized, investigator-blinded study investigated the efficacy and tolerability of adapalene gel 0.1% plus clindamycin phosphate lotion 1%, compared with clindamycin plus vehicle for the treatment of mild to moderate acne vulgaris. A total of 249 patients applied clindamycin lotion twice daily and adapalene (125 patients) or vehicle gel (124 patients) once daily for 12 weeks. A significantly greater reduction of total (P <.001), inflammatory (P =.004) and noninflammatory lesions (P <.001) was seen in the clindamycin plus adapalene group than in the clindamycin plus vehicle group. These significant treatment effects were observed as early as week 4 for both noninflammatory and total lesion counts. Both treatment regimens were well tolerated. Although the worst scores for scaling (P <.05), dryness (P <.01), and stinging/burning (P <.05) were higher in the clindamycin plus adapalene group than in the clindamycin plus vehicle group in patients with moderate or severe irritation; in most cases these symptoms were of mild intensity.
Similar articles
-
Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle.J Am Acad Dermatol. 2003 Sep;49(3 Suppl):S218-26. doi: 10.1067/s0190-9622(03)01153-8. J Am Acad Dermatol. 2003. PMID: 12963898 Clinical Trial.
-
The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.J Cosmet Dermatol. 2012 Dec;11(4):251-60. doi: 10.1111/jocd.12013. J Cosmet Dermatol. 2012. PMID: 23174047 Clinical Trial.
-
Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.Am J Clin Dermatol. 2011 Dec 1;12(6):407-20. doi: 10.2165/11208170-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967116 Review.
-
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.Arch Dermatol. 2006 May;142(5):597-602. doi: 10.1001/archderm.142.5.597. Arch Dermatol. 2006. PMID: 16702497 Clinical Trial.
-
Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.J Am Acad Dermatol. 2000 Aug;43(2 Pt 3):S51-4. doi: 10.1067/mjd.2000.108322. J Am Acad Dermatol. 2000. PMID: 10898831 Review.
Cited by
-
Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne.Perspect Clin Res. 2018 Oct-Dec;9(4):161-164. doi: 10.4103/picr.PICR_109_17. Perspect Clin Res. 2018. PMID: 30319945 Free PMC article.
-
Retinoid plus antimicrobial combination treatments for acne.Clin Cosmet Investig Dermatol. 2011;4:79-92. doi: 10.2147/CCID.S13873. Epub 2011 Jul 1. Clin Cosmet Investig Dermatol. 2011. PMID: 21760743 Free PMC article.
-
Observation for clinical effect of acupuncture combined with conventional therapy in the treatment of acne vulgaris.Medicine (Baltimore). 2020 May;99(18):e19764. doi: 10.1097/MD.0000000000019764. Medicine (Baltimore). 2020. PMID: 32358349 Free PMC article.
-
Adapalene: a review of its use in the treatment of acne vulgaris.Drugs. 2004;64(13):1465-78. doi: 10.2165/00003495-200464130-00005. Drugs. 2004. PMID: 15212561 Review.
-
Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.Dermatol Ther (Heidelb). 2024 Nov;14(11):3097-3112. doi: 10.1007/s13555-024-01286-x. Epub 2024 Nov 1. Dermatol Ther (Heidelb). 2024. PMID: 39487326 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical